Sponsored Ad

Lawson Health Research Institute Perspective London Globe and Mail

Lawson Health Research Institute Perspective London Globe and Mail

Lawson Health Research Institute Perspective London Globe and Mail

The SABR-COMET clinical trial included 51 patients from the London Regional Cancer Program at London Health Sciences Centre.